Christopher G. Twitty
Technik-/Wissenschafts-/F&E-Leiter bei SKYE BIOSCIENCE, INC.
Profil
Christopher G.
Twitty is currently the Chief Scientific Officer at Skye Bioscience, Inc. He previously worked as the Chief Scientific Officer at OncoSec Medical, Inc. from 2017 to 2021 and as the Chief Scientific Officer at Onchilles Pharma, Inc. He also served as an Independent Director at Larkspur Health Acquisition Corp.
Dr. Twitty earned a doctorate degree from Oregon Health & Science University.
Aktive Positionen von Christopher G. Twitty
Unternehmen | Position | Beginn |
---|---|---|
SKYE BIOSCIENCE, INC. | Technik-/Wissenschafts-/F&E-Leiter | 13.12.2022 |
Ehemalige bekannte Positionen von Christopher G. Twitty
Unternehmen | Position | Ende |
---|---|---|
ONCOSEC MEDICAL INCORPORATED | Technik-/Wissenschafts-/F&E-Leiter | 20.10.2021 |
Onchilles Pharma, Inc.
Onchilles Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Onchilles Pharma, Inc. engages in the provision of biotechnology services. The company is headquartered in San Diego, CA. | Technik-/Wissenschafts-/F&E-Leiter | - |
LARR HEALPAR | Direktor/Vorstandsmitglied | - |
Ausbildung von Christopher G. Twitty
Oregon Health & Science University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
ONCOSEC MEDICAL INCORPORATED | Health Services |
SKYE BIOSCIENCE, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Onchilles Pharma, Inc.
Onchilles Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Onchilles Pharma, Inc. engages in the provision of biotechnology services. The company is headquartered in San Diego, CA. | Commercial Services |
Larkspur Health Acquisition Corp.
Larkspur Health Acquisition Corp. Financial ConglomeratesFinance Larkspur Health Acquisition Corp. is a blank check company, which was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded on March 17, 2021 and is headquartered in Bridgewater, NJ. | Finance |